Newsletter Newsletters Events Events Podcasts Videos Africanews
Loader
Latest
Trending
Latest stories
Europe
Categories
Programmes
Featured
World
Categories
Programmes
Featured
EU Policy
Business
Categories
Programmes
Featured
Travel
Categories
Programmes
Next
Categories
Programmes
Featured
Culture
Categories
Programmes
Green
Categories
Programmes
Featured
Health
Categories
Programmes
Euroviews
Videos
More
Special coverage
Partner content
Services
Newsletter Newsletters Events Events Podcasts Videos Africanews
Loader
Find Us
Flipboard Instagram Linkedin
Advertisement

Uzbekistan builds pharma ambitions with €1.2bn investment in regional production and export hub

In partnership with
Uzbekistan builds pharma ambitions with €1.2bn investment in regional production and export hub
Copyright  Euronews
Copyright Euronews
By Damon Embling
Published on •Updated
Share this article
Share this article Close Button
Copy/paste the article video embed link below: Copy to clipboard Copied

Uzbekistan is rapidly scaling up its pharmaceutical sector with the launch of Tashkent Pharma Park — a €1.2 billion project uniting research, logistics, manufacturing and training.

ADVERTISEMENT

Uzbekistan is investing €1.2 billion into Tashkent Pharma Park, a massive new complex designed to boost pharmaceutical production, R&D and exports. The 1.9 million square metre site will include a biotech centre, technical university and manufacturing facilities — all within a free economic zone offering tax incentives. 

The country aims to produce €440 million worth of pharmaceutical products annually by 2025, with more than half earmarked for export. Domestic firms like Dentafill Plyus are already targeting new markets, while foreign partnerships are being encouraged. Officials say WTO-aligned standards and a focus on clinical trials are key to enabling exports to Europe and beyond. 

Go to accessibility shortcuts
Share this article

Read more